Glaukos Corp. has reported it will initiate an IDE pivotal trial for its Istent SA trabecular micro-bypass system among pseudophakic glaucoma patients. Research will evaluate the device against selective laser trabeculoplasty (SLT) as well as safety and efficacy in reducing intraocular pressure (IOP) at one year.